Prinsen BH - Search Results

1

Differences between acylcarnitine profiles in plasma and bloodspots.

de Sain-van der Velden MG, Diekman EF, Jans JJ, van der Ham M, Prinsen BH, Visser G, Verhoeven-Duif NM. de Sain-van der Velden MG, et al. Among authors: prinsen bh. Mol Genet Metab. 2013 Sep-Oct;110(1-2):116-21. doi: 10.1016/j.ymgme.2013.04.008. Epub 2013 Apr 13. Mol Genet Metab. 2013. PMID: 23639448

2

Idiopathic hypoalbuminemia explained by reduced synthesis rate and an increased catabolic rate.

Prinsen BH, Kaysen GA, Klomp LW, de Boer J, Barrett PH, Thornalley PJ, Battah S, Berger R, Rabelink TJ, de Sain-van der Velden MG. Prinsen BH, et al. Clin Biochem. 2002 Oct;35(7):545-53. doi: 10.1016/s0009-9120(02)00357-0. Clin Biochem. 2002. PMID: 12493583

3

Hypertriglyceridemia in patients with chronic renal failure: possible mechanisms.

Prinsen BH, de Sain-van der Velden MG, de Koning EJ, Koomans HA, Berger R, Rabelink TJ. Prinsen BH, et al. Kidney Int Suppl. 2003 May;(84):S121-4. doi: 10.1046/j.1523-1755.63.s84.34.x. Kidney Int Suppl. 2003. PMID: 12694325 Free article. Review.

4

Endogenous cholesterol synthesis is associated with VLDL-2 apoB-100 production in healthy humans.

Prinsen BH, Romijn JA, Bisschop PH, de Barse MM, Barrett PH, Ackermans M, Berger R, Rabelink TJ, de Sain-van der Velden MG. Prinsen BH, et al. J Lipid Res. 2003 Jul;44(7):1341-8. doi: 10.1194/jlr.M300023-JLR200. Epub 2003 Apr 16. J Lipid Res. 2003. PMID: 12700338 Free article.

5

Increased albumin and fibrinogen synthesis rate in patients with chronic renal failure.

Prinsen BH, Rabelink TJ, Beutler JJ, Kaysen GA, De Boer J, Boer WH, Hagen EC, Berger R, De Sain-Van Der Velden MG. Prinsen BH, et al. Kidney Int. 2003 Oct;64(4):1495-504. doi: 10.1046/j.1523-1755.2003.00211.x. Kidney Int. 2003. PMID: 12969171 Free article.

6

A broad-based metabolic approach to study VLDL apoB100 metabolism in patients with ESRD and patients treated with peritoneal dialysis.

Prinsen BH, Rabelink TJ, Romijn JA, Bisschop PH, de Barse MM, de Boer J, van Haeften TW, Barrett PH, Berger R, de Sain-van der Velden MG. Prinsen BH, et al. Kidney Int. 2004 Mar;65(3):1064-75. doi: 10.1111/j.1523-1755.2004.00466.x. Kidney Int. 2004. PMID: 14871427 Free article.

7

Components of the IGF system and not insulin itself are strongly associated with apoB100 kinetics in ESRD.

Twickler TB, Prinsen BH, de Sain-van der Velden MG. Twickler TB, et al. Among authors: prinsen bh. Kidney Int. 2004 Mar;65(3):1116-7. doi: 10.1111/j.1523-1755.2004.501_11.x. Kidney Int. 2004. PMID: 14871445 Free article. No abstract available.

8

Albumin turnover: experimental approach and its application in health and renal diseases.

Prinsen BH, de Sain-van der Velden MG. Prinsen BH, et al. Clin Chim Acta. 2004 Sep;347(1-2):1-14. doi: 10.1016/j.cccn.2004.04.005. Clin Chim Acta. 2004. PMID: 15313137 Review.

9

Enhanced conversion of triglyceride-rich lipoproteins and increased low-density lipoprotein removal in LPLS447X carriers.

Nierman MC, Prinsen BH, Rip J, Veldman RJ, Kuivenhoven JA, Kastelein JJ, de Sain-van der Velden MG, Stroes ES. Nierman MC, et al. Among authors: prinsen bh. Arterioscler Thromb Vasc Biol. 2005 Nov;25(11):2410-5. doi: 10.1161/01.ATV.0000188506.79946.ce. Epub 2005 Sep 29. Arterioscler Thromb Vasc Biol. 2005. PMID: 16195478 Clinical Trial.

10

Enhanced apoB48 metabolism in lipoprotein lipase X447 homozygotes.

Nierman MC, Rip J, Kuivenhoven JA, Sakai N, Kastelein JJ, de Sain-van der Velden MG, Stroes ES, Prinsen BH. Nierman MC, et al. Among authors: prinsen bh. Atherosclerosis. 2007 Oct;194(2):446-51. doi: 10.1016/j.atherosclerosis.2006.08.038. Epub 2006 Sep 20. Atherosclerosis. 2007. PMID: 16989840

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters